Story Stocks^®

Domino's Pizza (DPZ -10%) reported mixed Q1 results, but shares are under pressure following a second consecutive EPS miss and softer-than-expected same-store sales trends. Revenue increased 3.5% yr/yr to $1.15 bln, in-line with Street estimates. DPZ increased its share repurchase authorization by $1 bln .but that seems to not be helping the stock much.

• EPS missed expectations, marking the second consecutive quarterly miss and third in the past four quarters.
• US same-store sales rose just +0.9% in Q1, a sharp slowdown from +3.7% in Q4 and +5.2% in Q3. Full-year 2025 US comps were +3.0%, highlighting the deceleration entering 2026.
• While DPZ was pleased with its start to the year, performance for the rest of the quarter did not meet expectations. Pressure intensified throughout the quarter, in particular in March because of growing consumer uncertainty. Consumer sentiment hit COVID level lows and ongoing inflation continued to impact purchase decisions. Weather also affected its business in the quarter.
• FY26 guidance was lowered, with US same-store sales now expected to grow low single digits, down from prior +3% guidance.
• International same-store sales growth is now projected in the low single digits, below prior expectations of +1-2%.

Briefing.com Analyst Insight:

Domino's disappointing Q1 results reinforce concerns that the company is facing a tougher operating environment than previously anticipated. The sharp deceleration in U.S. same-store sales is particularly troubling, especially given management's prior optimism just a few months ago. Weak traffic trends, especially among more price-sensitive consumers, combined with rising competitive intensity, are creating a difficult backdrop. While the increased buyback authorization provides some capital return support, it does little to offset concerns about slowing demand and margin pressure. The FY26 guidance suggests that management is bracing for continued macro and competitive headwinds, making it harder to build confidence in a near-term reacceleration story.